Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Alimentary pharmacology & therapeutics 18 (2003), S. 0 
    ISSN: 1365-2036
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Background : Approximately 13 000 patients undergo pelvic radiotherapy annually in the UK. It is not clear how frequently patients develop a permanent change in bowel habit after pelvic radiotherapy that affects their quality of life because the measures of gastrointestinal toxicity used in trials in the past have generally been inadequate. It has been suggested that patients who are symptomatic are only rarely referred to a gastroenterologist and it is not known how patients manage their symptoms.Methods : Patients who had completed radiotherapy for pelvic cancer at least 1 year previously were invited to answer 30 structured questions in a face-to-face interview to determine the frequency of gastrointestinal symptoms and what orthodox, dietary and complementary therapies they used to deal with them. They were also asked to score the effectiveness of the measures they had taken.Results : One hundred and seven patients were recruited [35 males; median age, 65 years (range, 35–80 years); 72 females; median age, 67.5 years (range, 31–87 years)]. Eight had been treated for a gastrointestinal primary tumour, 34 for a urological tumour and 65 for gynaecological tumours. Eighty-seven patients (81%) described new-onset gastrointestinal problems starting after radiotherapy. These symptoms affected the quality of life in 56 patients (52%). Significant effects on the quality of life were caused by diarrhoea or constipation (n = 53), faecal leakage (n = 19), abdominal, rectal or perineal pain (n = 14) and rectal bleeding (n = 6). Fifty-nine patients had seen a doctor for their symptoms (86% found this helpful), 12 had seen a dietician or nurse (50% found this helpful) and 14 had seen alternative practitioners (88% found this helpful). Dietary manipulation generally did not improve symptoms, except in a small group of patients (14/15) who avoided raw vegetables to great benefit.Conclusions : At least 1 year after pelvic radiotherapy, gastrointestinal symptoms which have an adverse effect on the quality of life may be more common than generally reported. Patients found that advice from doctors and alternative practitioners was equally valuable. Dietary manipulation was generally unhelpful for gastrointestinal symptoms after pelvic radiotherapy, although the role of eliminating raw vegetables may benefit from further evaluation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Alimentary pharmacology & therapeutics 21 (2005), S. 0 
    ISSN: 1365-2036
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Background : Rectal bleeding after pelvic radiotherapy is often attributed to radiation proctitis and patients do not routinely undergo flexible endoscopy.Aims : To assess the significance of bleeding after radiotherapy.Methods : We maintained a prospective register of all such patients referred to our endoscopy unit.Results : One hundred and thirty-nine men (median age 70 years; range 31–82), and 32 women (median age 61 years; range 30–81) were referred with rectal bleeding (median 2 years; range 0–21) after pelvic radiotherapy. Primary tumour sites were urological (n = 139), gastrointestinal (n = 7) and gynaecological (n = 25). Ninety patients had bleeding alone; 81 had other symptoms. One hundred and forty-one had typical radiation proctitis; in 65 this was the sole diagnosis; eight had cancer, nine had high-risk adenomas, and six had three or more small adenomas. Ninety-five other diagnoses were made. Eleven (73%) patients with advanced polyps or cancer required only flexible sigmoidoscopy to make the diagnosis, while four (27%) diagnoses were made only after colonoscopy; 47% of these patients had no other symptoms apart from rectal bleeding.Conclusions : After pelvic radiotherapy, clinical symptoms are not reliable in differentiating between radiation proctitis alone or more significant pathology. It is mandatory that all patients with new onset rectal bleeding are investigated with, at least, flexible sigmoidoscopy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Cellular and molecular life sciences 16 (1960), S. 78-80 
    ISSN: 1420-9071
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Medicine
    Notes: Zusammenfassung Charakteristisch verschiedene Schwanzstellungen zeigen Albino-Ratten und -Mäuse als Morphium- bzw. Reserpinreaktion. Verstärkte Schwanzreaktionen erhält man bei der Maus nach Morphium, bei der Ratte nach Reserpin. Methylphenidat erweist sich bei der Ratte antagonistisch gegen Reserpin, während im Mäuseversuch nach Reserpin injiziertes Morphium kompetitiv zu wirken scheint.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-2072
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Concurrent observations were made on the rope-climbing performance and aromatic excretion pattern of male albino rats during drug treatment. Iproniazid, Niamid and Isoniazid were administered chronically and Reserpine was given in single doses, alone, and in combination with the Iproniazid. 1. Iproniazid and Niamid disturbed the climbing habit which later became re-established even though drug treatment was continued. Urinary concentrations of 5-hydroxyindoleacetic acid fell and of tryptamine rose immediately on giving the drugs, and tryptophane excretion gradually increased. 2. Isoniazid had little effect on climbing performance. 3. A study of T.M. 6 was abandoned when large sores developed at the site of injection. 4. Reserpine given alone disrupted climbing and potentiated excretion of 5-hydroxyindoleacetic acid, tryptophane and two unidentified Ehrlich positive materials. 5. When given on the second day of Iproniazid treatment, Reserpine also disrupted climbing and increased excretion of 5-hydroxyindoleacetic acid, tryptamine and tryptophane. When given on the 23rd day, the climbing performance was impaired but no change was observed in excretion pattern. 6. Some physiological and overall behaviour changes during the experiments are described.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1569-8041
    Keywords: chemotherapy ; cisplatin ; radiotherapy ; response ; seminoma
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: The residual mass so frequently found after chemotherapyof advanced seminoma may consist entirely of benign tissue or may containresidual disease amenable to adjuvant therapy. Patients and methods: A detailed retrospective analysis was performedon 45 patients treated with cisplatin based chemotherapy for advanced seminomabetween 1978 and 1994. Results: The probability of a residual mass after chemotherapy washigher if the pre-treatment mass diameter was 〉5 cm (78%versus 15%, P = 0.0009). Of 33 patients with residual massesfollowing cisplatin chemotherapy, 4 were explored surgically showing fibrosisonly, 15 were treated by adjuvant radiotherapy and 14 were managed byobservation alone. Recurrence occurred in 2 of 14 patients managed byobservation and in 2 of 15 managed by radiotherapy. There was no evidence thatrisk of recurrence was related to diameter of residual mass. Conclusion: Residual masses persisted following cisplatin basedcombination chemotherapy for seminoma in 73% of cases. In our study,recurrence was rare and there was no evidence that this was influenced byeither the size of the residual mass or the use of adjuvant therapy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1432-1335
    Keywords: Granisetron ; Metoclopramide ; Dexamethasone ; Fractionated chemotherapy ; Emesis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The antiemetic efficacy and safety of granisetron (40 μg/kg), a selective and potent 5-hydroxytryptamine (serotonin) antagonist, was compared with that of metoclopramide (7 mg/kg) plus dexamethasone (12 mg) in patients receiving fractionated chemotherapy. Patients receiving cisplatin at doses of at least 15 mg/m2 or etoposide at least 120 mg/m2 or ifosfamide at least 1.2 g/m2 on each of 5 consecutive days were eligible. A total of 143 patients received granisetron and 141 received the comparator regimen. The 5-day complete response rate (no vomiting, no worse than mild nausea) for granisetron (46.8%) was equivalent to that for metoclopramide plus dexamethasone (43.9%). The overall 5-day response profile was superior for granisetron (P=0.013) because of fewer failures in this group. The overall incidence of adverse experiences was significantly lower in the granisetron group (60.8% versus 77.3%,P=0.003). Headache and constipation, more prevalent in the granisetron group, are recognized side-effects of serotonin antagonists. Extrapyramidal syndrome, not seen in any granisetron patients, occurred in 20.6% of comparator patients (P〈0.0001). The majority of granisetron patients only required a single prophylactic dose of the drug on each treatment day (at least 82%). In conclusion, granisetron showed at least equivalent efficacy to metoclopramide plus dexamethasone in patients receiving 5-day fractionated chemotherapy. In addition it offered a simple and convenient dosing regimen and a safer side-effect profile.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...